
IonQ enters DARPA Stage C under agreement worth up to US$300M
Funding beyond the undisclosed initial obligation depends on future appropriations as DARPA tests IonQ systems through 2029.

The company says its 3-MMC claims cover dyskinesia treatment alone and with PEA, but gave no publication number or grant timetable.

Funding beyond the undisclosed initial obligation depends on future appropriations as DARPA tests IonQ systems through 2029.

Brazil's ANP awarded 462.4 square kilometres, with work due over three years on a marginal field and six years on exploration blocks.
The Oct. 6 departure took effect immediately, while SNDL's board page still listed Cannell among seven directors on Oct. 7.
Absentee ballots closed Oct. 6; the Oct. 7 results showed shareholders approved the SNURDC transaction but did not approve the Uranium One proposal.

First reading starts a hearing process for Bell's conditional land purchase; Bell proposes up to 900 MW of additional power.

Saxony-Anhalt licensed new production areas in Leuna, but Aurora gave no tonnage or timetable for deliveries from the expanded site.

Gross margin widened to 30 per cent, but cannabis revenue declined; Tilray retained its fiscal 2027 adjusted EBITDA target.

A European Radiology paper tested DeepHealth's MRI risk score on 787 men; simulated biopsy savings have yet to be shown in practice.
An unnamed MISO Zone 6 utility will buy Merom capacity and contingent power from June 2029, with part of the revenue tied to forward prices.
A second AG infill hole returned 37.2m at 177.7 g/t silver equivalent, while lower elevation drilling continues.
The Oct. 7 results show 250 MW live at Polaris Forge 1 after quarter end, while the 210 MW Delta Forge 2 lease dates to June.
In docket EB-2026-0164, the utility forecasts transmission rate base rising from C$19.2B in 2028 to C$28.5B in 2032.
Hole CS26-096 also cut 101.6 metres at 1.02 per cent lithium oxide entirely outside the conceptual pit shell used in April's resource estimate.
Scout says Oracle's VPPA covers a majority of the output from its operating 300 MW Ranchero farm; contracted megawatts, price and start date were not disclosed.
Chevron's DJ Basin service agreements and revised Bakken contracts run through 2045; lower Bakken tariffs apply from 2027 through 2033.
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
PEJ instructed Westinghouse to begin ordering long lead components for the first Lubiatowo-Kopalino unit as wider EPC terms remain under negotiation.
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
The designations cover a colorectal cancer combination and lung cancer monotherapy, both based mainly on a first-in-human study.
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
The CMA will consult on sales of NoteMachine and TestLink’s UK business before deciding whether to clear the pending NCR Atleos acquisition.
The Oct. 16 proposal seeks approval for up to 435,859,500 shares, with control passing to Metaplanet Holdings if the deal closes.
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
The 120,000-square-foot hub consolidates stock from Barrie; the Oct. 7 opening notice gives no Orillia rate-base allocation.

Preliminary results of Rock Tech's ongoing definitive feasibility study use a Red Rock design capacity of about 30,000 tonnes of lithium salts a year.

Wedgemount’s three-year option ended with no termination payment, removing a route to C$4M in staged exploration spending.
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Trulieve's Oct. 7 release says notes secured by its Jefferson County cultivation site were repaid, leaving about US$225M of debt.

The live application separates medical marijuana manufacturers, distributors and labs; state licences remain a condition of registration.

The Oct. 5 rule caps adult-use edibles at 10 milligrams per serving and 100 milligrams per package; medical edibles have higher caps.

An Oct. 6 SEC amendment identifies a SEDAR+ notice changing the bid's consideration and expiry after Curaleaf announced new cash and share terms.